These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16710126)

  • 1. [From psychometry to neuropsychological disability in multiple sclerosis: a new brief French cognitive screening battery and cognitive risk factors].
    Sartori E; Belliard S; Chevrier C; Trebon P; Chaperon J; Edan G
    Rev Neurol (Paris); 2006 May; 162(5):603-15. PubMed ID: 16710126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
    Lapshin H; Lanctôt KL; O'Connor P; Feinstein A
    Mult Scler; 2013 Dec; 19(14):1905-12. PubMed ID: 23652217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normalization of the Brief Repeatable Battery of Neuropsychological tests (BRB-N) for German-speaking regions. Application in relapsing-remitting and secondary progressive multiple sclerosis patients].
    Scherer P; Baum K; Bauer H; Göhler H; Miltenburger C
    Nervenarzt; 2004 Oct; 75(10):984-90. PubMed ID: 15118827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between EDSS and cognitive impairment in MS patients. Assessment of a Brazilian population using a BICAMS version.
    Caneda MA; Vecino MC
    Arq Neuropsiquiatr; 2016 Dec; 74(12):974-981. PubMed ID: 27991994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verbal fluency deficits in multiple sclerosis.
    Henry JD; Beatty WW
    Neuropsychologia; 2006; 44(7):1166-74. PubMed ID: 16293271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to detect cognitive dysfunction at early stages of multiple sclerosis?
    Deloire MS; Bonnet MC; Salort E; Arimone Y; Boudineau M; Petry KG; Brochet B
    Mult Scler; 2006 Aug; 12(4):445-52. PubMed ID: 16900758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    Vázquez-Marrufo M; Galvao-Carmona A; Caballero-Díaz R; Borges M; Paramo MD; Benítez-Lugo ML; Ruiz-Peña JL; Izquierdo G
    PLoS One; 2019; 14(7):e0219594. PubMed ID: 31306457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cognitive dysfunction in multiple sclerosis.
    Sartori E; Edan G
    J Neurol Sci; 2006 Jun; 245(1-2):169-75. PubMed ID: 16678209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.
    Negreiros MA; Mattos P; Landeira-Fernandez J; Paes RA; Alvarenga RP
    Brain Inj; 2008 May; 22(5):419-26. PubMed ID: 18415722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of frontal dysfunctions in relapsing-remitting multiple sclerosis.
    Santiago O; Guàrdia J; Casado V; Carmona O; Arbizu T
    Arch Clin Neuropsychol; 2007 Jun; 22(5):623-9. PubMed ID: 17482795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.
    Heesen C; Gold SM; Raji A; Wiedemann K; Schulz KH
    Psychoneuroendocrinology; 2002 May; 27(4):505-17. PubMed ID: 11912002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three screening batteries to detect cognitive impairment in multiple sclerosis.
    Aupperle RL; Beatty WW; Shelton Fde N; Gontkovsky ST
    Mult Scler; 2002 Oct; 8(5):382-9. PubMed ID: 12356204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.